Mark McKenzie, M.D. is the Chief Medical Officer responsible for strategies and new initiatives in the clinical and therapeutic areas. He also provides medical and clinical oversight to EmVenio’s team of principal investigators involved in trials at community research sites globally. Dr. McKenzie joined EmVenio Research in 2023 with more than 20 years of experience facilitating clinical trials.
Prior to joining EmVenio Research, Dr. McKenzie served as Vice President of Clinical Affairs at M-3 Wake Research, where he was responsible for clinical operations, marketing, business development, and regulatory affairs. Previously, he was the regional medical director and principal investigator at ClinSearch.
Dr. McKenzie earned a Bachelor of Arts in Biology from Southern Adventist University and later returned to earn a Bachelor of Science in medical technology. He then received his doctorate from the Medical College of Ohio at the University of Toledo.